Correction: Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination

• Dorota Zarębska-Michaluk,
• Michał Brzdęk,
• Olga Tronina,
• Justyna Janocha-Litwin,
• Marek Sitko,
• Anna Piekarska,
• Jakub Klapaczyński,
• Anna Parfieniuk-Kowerda,
• Barbara Sobala-Szczygieł,
• Magdalena Tudrujek-Zdunek,
• Łukasz Laurans,
• Robert Flisiak

Affiliations

Dorota Zarębska-Michaluk

Department of Infectious Diseases and Allergology, Jan Kochanowski University

Michał Brzdęk

Collegium Medicumm, Jan Kochanowski University

Olga Tronina

Department of Transplantology, Immunology, Nephrology and Internal Diseases, Medical University of Warsaw

Justyna Janocha-Litwin

Department of Infectious Diseases and Hepatology, Wrocław Medical University

Marek Sitko

Department of Infectious and Tropical Diseases, Jagiellonian University

Anna Piekarska

Department of Infectious Diseases and Hepatology, Medical University of Łódź

Jakub Klapaczyński

Department of Internal Medicine and Hepatology, The National Institute of Medicine of the Ministry of Interior and Administration

Anna Parfieniuk-Kowerda

Department of Infectious Diseases and Hepatology, Medical University of Białystok

Barbara Sobala-Szczygieł

Department of Infectious Diseases and Hepatology, Medical University of Silesia in Katowice

Magdalena Tudrujek-Zdunek

Department of Infectious Diseases, Medical University of Lublin

Łukasz Laurans

Department of Infectious Diseases, Hepatology and Liver Transplantation, Pomeranian Medical University

Robert Flisiak

Department of Infectious Diseases and Hepatology, Medical University of Białystok